More blood pressure medicines recalled over possible cancer-causing impurity
A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in more batches of the drug, federal health officials said. Three additional lots of losartan potassium tablets and two additional lots of losartan potassium/hydrochlorothiazide tablets were The lots contained levels of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) above the acceptable daily intake levels determined by the FDA. NMBA is a "potential human carcinogen," the ...
Click
To Read Full Article